New aspects of the thrombogenic effect of oral contraceptives.
D000991:Antithrombins; D001778:Blood Coagulation Disorders / Q000235:genetics; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003327:Coronary Disease / Q000139:chemically induced; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008656:Mestranol / Q000009:adverse effects; D009203:Myocardial Infarction / Q000139:chemically induced; D011372:Progestins / Q000009:adverse effects; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced*
D000991:Antithrombins; D003276:Contraceptives, Oral; D011372:Progestins; D004997:Ethinyl Estradiol; D008656:Mestranol